Welcome to Pathology News’ latest conference report. We were delighted to have our fantastic medical writer, Christos Evangelou, report from sunny San Diego, bringing us key insights from the SPIE Digital and Computational Pathology Conference 2025.

The landscape of digital and computational pathology is advancing rapidly, with artificial intelligence (AI) and advanced computational methods reshaping the way diseases are diagnosed, graded, and understood. This year’s conference showcased some of these advancements in the field. The Pathology News team is excited to introduce a new article series that brings these innovations to you, focusing on the key discussions and breakthroughs from the conference.

Over the coming weeks, we will explore emerging technologies, novel research, and transformative AI applications that are set to redefine pathology and patient care.

What’s in Store?

This series will spotlight the most exciting digital and computational pathology developments presented at SPIE 2025, including but not limited to:

• AI-Powered Diagnostics: From TP53 mutation analysis in leukemia to prostate cancer prognosis without Gleason grading, AI is accelerating clinical workflows and improving prognostic accuracy.
• Computational Breakthroughs in Neurodegenerative Disease: Graph-based AI models are distinguishing between rapid and classic Alzheimer’s disease, offering deeper insights into disease progression.
• Advancements in Model Interpretability: The rise of human-in-the-loop AI frameworks is bridging the trust gap, allowing pathologists to fine-tune AI outputs for clinical decision-making.
• Multimodal Imaging and Analysis: Cutting-edge imaging reveals cellular neighborhood patterns in quiescent Crohn’s disease, challenging assumptions about disease remission.
• The Future of Pathology AI: Moving beyond pattern recognition, researchers are developing adaptive AI systems that integrate across the patient’s diagnostic and treatment journey.

Why You Should Stay Tuned

Each article in this series will look into a key theme or research breakthrough, breaking down the science, exploring its implications, and discussing how these advancements may shape the future of pathology.

The first feature in our series, launching soon, will focus on how AI and computational tools are redefining disease diagnosis and grading, with a spotlight on Alzheimer’s disease biomarker research and new approaches in cancer pathology.

Join the conversation on our LinkedIn. We want to foster discussion and engagement with the global pathology community. What topics are you most excited about? What are your thoughts on the intersection of AI and digital pathology? Share your perspectives in the comments or reach out to us directly.

Stay tuned for the first article in our SPIE 2025 series, coming soon!